Global prevalence of cannabis and amphetamine/methamphetamine use among adolescents in 47 countries: a population-based study from WHO database
- PMID: 40108046
- DOI: 10.1007/s12519-025-00883-w
Global prevalence of cannabis and amphetamine/methamphetamine use among adolescents in 47 countries: a population-based study from WHO database
Abstract
Background: Adolescent drug use poses significant public health challenges worldwide, with detrimental effects on mental and physical health. Most existing research focuses on Western countries, holding a gap in understanding drug use in low- and middle-income countries. Thus, we aimed to assess the prevalence of cannabis and amphetamine or methamphetamine use among school-going adolescents aged 12-15 years across 47 countries globally.
Methods: We used data from the Global School-based Student Health Survey from 47 countries (2009-2018) to analyze cannabis and amphetamine/methamphetamine use and age at first drug use among adolescents (n = 220,362). A meta-analysis utilizing random-effects models estimated prevalence rates and weighted linear regression analyzed trends. Student's t tests were used to compare two-subgroup categories, while one-way ANOVA was employed for analyses involving the four-subgroup category. Stratification analysis by sex, World Bank income category, region, and country-specific characteristics based on World Health Organization data were also performed.
Results: The study included a total of 220,362 school-going adolescents aged 12-15 years (49.96% girls) from 47 countries. The overall prevalence of cannabis use was 7.02% [95% confidence interval (CI) 6.16-7.89], with higher usage among boys [9.20% (95% CI 8.05-10.36)] compared to girls [4.20% (95% CI 3.68-4.72)]. Amphetamine/methamphetamine use prevalence was 4.05% (95% CI 3.51-4.60), also higher among boys [5.14% (95% CI 4.45-5.84)] than girls [2.34% (95% CI 2.00-2.69)]. The region of the Americas exhibited the highest prevalence of cannabis use [11.31% (95% CI 8.44-14.17)], while the African region showed the highest prevalence of amphetamine use [4.34% (95% CI 3.14-5.53)]. High-income countries reported the highest prevalence of cannabis use [9.45% (95% CI, 6.06 to 12.84)], whereas low-income countries had the lowest [3.46% (95% CI 2.01-4.91)]. Higher prevalence rates were associated with countries having higher homicide rates, better sanitation services, and higher health expenditures.
Conclusions: Cannabis use among adolescents is more prevalent than amphetamine or methamphetamine use, with significant sex differences showing higher prevalence among boys. The highest prevalence of cannabis use was observed in Latin America, while Africa exhibited the highest rates of amphetamine use. Findings from the present study indicate a need for public policies and programs targeting adolescents to effectively reduce adolescent drug use.
Keywords: Adolescents; Amphetamine; Cannabis; Drug; Methamphetamine; World Health Organization.
© 2025. Children's Hospital, Zhejiang University School of Medicine.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no competing interests. No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The author YDK is a member of the editorial board for World Journal of Pediatrics. The paper was handled by the other editor and has undergone rigorous peer review process. The author YDK was not involved in the journal’s review of, or decision related to this manuscript. Ethical approval: All GSHS surveys and protocols were approved by each country’s government agency (primarily the Ministry of Health or Education), institutional ethics committees, and the US Centers for Disease Control and Prevention (CDC). Participant anonymity and voluntary participation were ensured, and data were statistically weighted to adjust for non-response and sampling variations.
Similar articles
-
Global trends in insufficient physical activity among adolescents: a pooled analysis of 298 population-based surveys with 1·6 million participants.Lancet Child Adolesc Health. 2020 Jan;4(1):23-35. doi: 10.1016/S2352-4642(19)30323-2. Epub 2019 Nov 21. Lancet Child Adolesc Health. 2020. PMID: 31761562 Free PMC article.
-
Cannabis and amphetamine use among school-going adolescents in sub-Saharan Africa: a multi-country analysis of prevalence and associated factors.BMC Psychiatry. 2023 Oct 24;23(1):778. doi: 10.1186/s12888-023-05283-w. BMC Psychiatry. 2023. PMID: 37875858 Free PMC article.
-
Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.Lancet Psychiatry. 2023 Feb;10(2):85-97. doi: 10.1016/S2215-0366(22)00339-X. Lancet Psychiatry. 2023. PMID: 36697127 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
The 2023 Latin America report of the Lancet Countdown on health and climate change: the imperative for health-centred climate-resilient development.Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May. Lancet Reg Health Am. 2024. PMID: 38800647 Free PMC article. Review.
Cited by
-
Impact of conventional cigarette and electronic cigarette use on sperm quality and IVF/ICSI outcomes.Sci Rep. 2025 Jul 3;15(1):23714. doi: 10.1038/s41598-025-09495-w. Sci Rep. 2025. PMID: 40610584 Free PMC article.
References
-
- Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5:987–1012.
-
- Formanek T, Krupchanka D, Mlada K, Winkler P, Jones PB. Mortality and life-years lost following subsequent physical comorbidity in people with pre-existing substance use disorders: a national registry-based retrospective cohort study of hospitalised individuals in Czechia. Lancet Psychiatry. 2022;9:957–68.
-
- Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379:55–70.
-
- Anderson DM, Fe HT, Liang Y, Sabia JJ. Recreational marijuana laws and teen marijuana Use, 1993–2021. JAMA Psychiat. 2024;81:840–2.
-
- Castaldelli-Maia JM, Wang YP, Brunoni AR, Faro A, Guimaraes RA, Lucchetti G, et al. Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet Psychiatry. 2023;10:85–97. - PMC
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous